FIGURE 1.
CONSORT flow diagram. After meeting the inclusion criteria, study participants were randomly assigned (1:1) to the AZD4017 group (800 mg/d in two divided oral doses) or matched placebo group for 12 weeks (±1 week) of treatment
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.